Biotechnology
3
Vaud
2020
Seed
Revolutionize GPCR drug discovery
We develop a new microfluidic system that makes it faster and easier to discover new drugs targeting cell membrane proteins (GPCRs) for major diseases like cancer, Alzheimer’s, Parkinson’s and cardiovascular illness.
Social Media:
Website
LinkedIn